Loss of protein tyrosine phosphatase receptor delta PTPRD increases the number of cortical neurons, impairs synaptic function and induces autistic-like behaviors in adult mice.

Publication date: Jun 18, 2024

The brain cortex is responsible for many higher-level cognitive functions. Disruptions during cortical development have long-lasting consequences on brain function and are associated with the etiology of brain disorders. We previously found that the protein tyrosine phosphatase receptor delta Ptprd, which is genetically associated with several human neurodevelopmental disorders, is essential to cortical brain development. Loss of Ptprd expression induced an aberrant increase of excitatory neurons in embryonic and neonatal mice by hyper-activating the pro-neurogenic receptors TrkB and PDGFRβ in neural precursor cells. However, whether these alterations have long-lasting consequences in adulthood remains unknown. Here, we found that in Ptprd+/- or Ptprd-/- mice, the developmental increase of excitatory neurons persists through adulthood, affecting excitatory synaptic function in the medial prefrontal cortex. Likewise, heterozygosity or homozygosity for Ptprd also induced an increase of inhibitory cortical GABAergic neurons and impaired inhibitory synaptic transmission. Lastly, Ptprd+/- or Ptprd-/- mice displayed autistic-like behaviors and no learning and memory impairments or anxiety. These results indicate that loss of Ptprd has long-lasting effects on cortical neuron number and synaptic function that may aberrantly impact ASD-like behaviors.

Open Access PDF

Concepts Keywords
Aberrantly Animals
Mice Anxiety
Neurodevelopmental ASD
Pro Autistic Disorder
Proteins Cerebral Cortex
Disease Models, Animal
Female
Learning
Male
Medial prefrontal cortex
Memory
Mice
Mice, Knockout
Neurons
Ptprd protein, mouse
Synaptic Transmission
Synaptic transmission

Semantics

Type Source Name
drug DRUGBANK L-Tyrosine
disease MESH etiology
disease MESH brain disorders
disease MESH neurodevelopmental disorders
drug DRUGBANK Tretamine
drug DRUGBANK Isoxaflutole
disease MESH autism spectrum disorder
disease MESH schizophrenia
disease MESH bipolar disorder
disease MESH attention deficit hyperactivity disorder
disease MESH intellectual disability
drug DRUGBANK Water
drug DRUGBANK Isoflurane
drug DRUGBANK Sucrose
drug DRUGBANK Somatostatin
drug DRUGBANK Choline
drug DRUGBANK Potassium Chloride
drug DRUGBANK Sodium bicarbonate
drug DRUGBANK Dextrose unspecified form
drug DRUGBANK Ascorbic acid
drug DRUGBANK Magnesium sulfate
drug DRUGBANK Picrotoxin
drug DRUGBANK Tetrodotoxin
drug DRUGBANK Ketamine
drug DRUGBANK Dimethyl sulfoxide
drug DRUGBANK Methylergometrine
drug DRUGBANK Abacavir
drug DRUGBANK Esomeprazole
drug DRUGBANK Trestolone
drug DRUGBANK Apomorphine
drug DRUGBANK Proline
disease MESH cognitive impairments
disease MESH obsessive compulsive disorder
disease MESH weight loss
disease MESH Malformations
disease MESH Autism
drug DRUGBANK Serotonin
drug DRUGBANK Manganese
drug DRUGBANK Neuropeptide Y
disease MESH anxiety disorders
disease MESH restless Leg syndrome
drug DRUGBANK Cocaine
disease MESH cortical dysplasias
disease MESH Disease Models Animal

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *